Atlas Trials

Study Evaluating Ascending Single-Dose Of Bosutinib Administered With Multiple Doses Of Ketoconazole To Healthy Subjects

Clinical trial NCT00777530 · COMPLETED

Trial details

NCT number
NCT00777530
Sponsor
Wyeth is now a wholly owned subsidiary of Pfizer
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Breast CancerTumorsLeukemia
Start date
2008-04-01
Primary completion
2008-08-01
Enrollment
48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.